HIMS Stock Forecast & Price Target

Hims & Hers Health has demonstrated significant membership growth, with a 55% year-over-year increase in subscribers utilizing personalized products, which now constitute approximately 65% of the total membership as of the third quarter of 2025. Financial projections indicate substantial growth potential, with expectations of international revenue rising to nearly $1 billion by fiscal year 2030, reflecting nearly a tenfold increase from the fiscal year 2025 run rate due to expansion into new treatments and markets. Additionally, core U.S. revenue is anticipated to grow at an annual rate of approximately 21%, driven primarily by subscriber growth and enhanced revenue per subscriber through personalized services and new treatment offerings.

Hims & Hers Health has experienced significant volatility, with stock performance highlighting a decline of over 20% since late July, despite a year-to-date increase of more than double its value. Key concerns affecting the company's outlook include the slower adoption of personalized treatments impacting revenue growth, ongoing regulatory uncertainties in the healthcare industry that could alter its business model, and heightened competition within the digital health sector. Additionally, the firm's reliance on consumer discretionary spending poses a risk, as adverse macroeconomic conditions could further hinder its ability to sustain growth.